A pilot double-blind, randomized, and placebo-controlled study of orally administered IFN-α-n1 (Ins) in pediatric patients with measles

Journal of Interferon and Cytokine Research

Volumn 18, Issue 9, 1998, Pages 647-652

  Lecciones, Julius A ^a   Abejar, Norma H ^b   Dimaano, Efren E ^b   Bartolome, Regina ^a   Cinco, Silvina ^b   Mariano, Noel ^b   Yerro, Marie Elizabeth ^b   Cobar, Susan ^b   Fuggan, Bernadette ^b  

^a Philippine Children's Medical Center   (Philippines)

^b San Lazaro Hospital   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BIOLOGICAL RESPONSE MODIFIER; PLACEBO;

ADOLESCENT; ARTICLE; BRONCHOPNEUMONIA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPING COUNTRY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFANT; MALE; MEASLES; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; TREATMENT OUTCOME;

EID: 0031670817     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.647     Document Type: Article

References (30)

1. NATIONAL EPIDEMIC SENTINEL SURVEILLANCE SYSTEM, DEPARTMENT OF HEALTH, REPUBLIC OF THE PHILIPPINES. (1991). Measles. Field Epidemiology Training Program, Annual Report 1990 and 1991, pp. 62-70.
2. GERSHON, A.A. (1985). Measles virus (rubeola). In: Principles and Practices of Infectious Diseases, 3rd ed. G.A. Mandell (ed.) New York: Churchill Livingstone, 137, 1279-1286.
3. SHAFER, T.W., LIEBERMAN, M., COHEN, M., and CAME, P.E. (1972). Interferon administered orally: protection of neonatal mice from lethal virus challenge. Science 176, 1326-1327.
4. CUMMINS, J.M., TOMPKINS, M.B., OLSEN, R.G., TOMPKINS, W.A., and LEWIS, M.G. (1988). Oral use of human interferon alfa in cats. J. Biol. Response Mod. 7, 513-523.
5. CUMMINS, J.M., and HUTCHESON, D.P. (1983). Effect of interferon on feedlot cattle. Proc. Am. Assoc. Bovine Pract. 15, 109-115.
6. CUMMINS, J.M., and HUTCHESON, D.P. (1986). Low dosage of interferon to enhance vaccine efficiency in feedlot cattle. Proc. Am. Assoc. Bovine Pract. 18, 135-138.
7. HUTCHINSON, V.A., and CUMMINS, J.M. (1987). Low-dose oral interferon in a patient with AIDS. Lancet 2, 1530-1531.
8. HUTCHINSON, V.A., ANGENEND, J.L., MOK, W.L., et al. (1990). Chronic recurrent aphthous stomatitis: oral treatment with low dose interferon alfa. Mol. Biother. 2, 160-164.
9. KOECH, D.K., and OBEL, A.O. (1990). Efficacy of KEMRON (Low dose oral natural human interferon alfa) in the management of HIV-1 infection and acquired immune deficiency syndrome (AIDS). East Afr. Med. J. (Special Suppl.) 67, 64-70.
10. KOECH, D.K., and OBEL, A.O. (1990). Treatment of HIV infections and AIDS: new horizons. East Afr. Med. J. (Special Suppl.) 67, 77-81.
11. KOECH, D.K., OBEL, A.O., MINOWADA, J., et al. (1990). Low dose oral interferon alfa therapy for patients seropositive for human immunodeficiency virus type-1 (HIV-1). Mol. Biother. 2, 91-95.
12. GAO, Y., FENG, B., TAO, Q., and SUN, Y. (1993). A study on Immulin therapy of chronic hepatitis B. J. Beijing Med. U. 25, 97-99.
13. BILLIAU, A., NIETHAMMER, D., and STRANDER, H. (1986). Trials with interferon in cancer patients in Europe. In: Clinical Pharmacology. Clinical Application of Interferons and Their Inducers. D.A. Stringfellow (ed.) New York: Marcel Dekker, 3, 119-131.
14. BORDEN, E.C., and KROWN, S.E. (1986). Clinical trials in neoplastic disease in the United States. In: Clinical Pharmacology. Clinical Application of Interferons and Their Inducers. D.A. Stringfellow (ed.) New York: Marcel Dekker, 3, 101-118.
15. BOTTOMLEY, J.M., and TOY, J.L. (1985). Clinical side effects and toxicities of interferon. In: Interferon: In Vivo and Clinical Studies. N.B. Finter and R.K. Oldham (eds.) New York: Elsevier Science Publishers, 4, 156-180.
16. SCOTT, G.M. (1983). The toxic effects of interferon in man. In: Interferon 5. San Diego, CA: Academic Press, pp. 86-114.
17. BALKWILL, F.R., and BURKE, F. (1989). The cytokine network. Immunol. Today. 10, 299-304.
18. PESKA, S., LABDON, J.E., RASHIDBAIGI, A., et al. (1985). The human interferons: structure, biological activity and receptors. In: The Biology of the Interferon System 1984. H. Kirchner and H. Schellekens (eds.) New York: Elsevier Science Publishers, pp. 3-11.
19. RASHIDBAIGI, A., and PESKA, S. (1987). Interferons: protein structure. In: The Interferon System - A Current Review. S. Baron, F. Dianzani, J. Stanton, and W. Fleischmann, Jr. (eds.) Austin, TX: University of Texas Press, pp. 149-168.
20. HO, M. (1986). Clinical trials of interferon against viral diseases: United States. In: Clinical Pharmacology. Clinical Application of Interferons and Their Inducers. D.A. Stringfellow (ed.) New York: Marcel Dekker, 3, 133-147.
21. YAMAZAKI, S. (1986). Clinical trials of interferons in Japan in viral and neoplastic diseases. In: Clinical Pharmacology. Clinical Application of Interferons and Their Inducers. D.A. Stringfellow (ed.) New York: Marcel Dekker, 3, 197-216.
22. BOCCI, V. (1991). Absorption of cytokines via oropharyngeal-associated lymphoid tissues. Does an unorthodox route improve the therapeutic index of interferon? Clin. Pharmacokinet. 21, 411-417.
23. CRAGO, S.S., PRINCE, S.J., PRETLOW, T.G., McGHEE, J.R., and MESTECKY, J. (1979). Human colostral cells: I: separation and characterization. Clin. Exp. Immunol. 38, 585-597.
24. OGRA, S.S., and OGRA, P.L. (1978) Immunologic aspects of human colostrum and milk II: characteristics of lymphocyte reactivity and distribution of E-rosette forming cells at different times after the onset of lactation. J. Pediatr. 92, 550-555.
25. BUTCHER, E.C. (1986). The regulation of lymphocyte traffic. Curr. Top. Microbiol. Immunol. 128, 85-122.
26. BOCCI, V. (1985). Immunomodulators as local hormones: new insights regarding their clinical utilization. J. Biol. Response Mod. 4, 340-352.
27. BOCCOLI, G., MASCIULLI, R., RUGGERI, E.M., CARLINI, P., GIANELLA, G., et al. (1990). Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high-dose interleukin 2 bolus treatment. Cancer Res. 50, 5795-5800.
28. DINARELLO, C.A., CANNON, J.G., WOLFF, S.M., BERNHEIM, H.A., BEUTLER, B., et al. (1986). Tumour necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1. J. Exp. Med. 163, 1433-1450.
29. BLALOCK, J.E., BARON, S., JOHNSON, H.M., and STANTON, G.J. (1982). Transmission of IFN-induced activities by cell-to-cell communication. Texas Rep. Biol. Med. 41, 344-349.
30. YASHUI, H., PROTETTI, E., VIGNAUX, F., EID, P., and GRESSER, I. (1980). Inhibition by mouse α-interferon of the multiplication of α-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes. Cancer Res. 50, 3533-3539.